Literature DB >> 3180970

Organic anions and the diarrhea of inflammatory bowel disease.

P Vernia1, A Gnaedinger, W Hauck, R I Breuer.   

Abstract

To determine if organic anions contribute to the diarrhea of inflammatory bowel disease, we measured osmolality, electrolytes, short-chain fatty acids, lactic acid, and some Krebs cycle anions in 24-hr fecal collections from 18 patients with chronic ulcerative colitis, 20 with Crohn's disease of the colon, and 16 normals. Mean lactic acid concentration was significantly elevated in ulcerative and Crohn's colitis, but values correlated with fecal weight only in the former syndrome. In ulcerative colitis, concentrations of each short-chain fatty acid, especially butyrate, were decreased compared with those from normals or Crohn's disease. Lactate and short-chain fatty acids accounted for nearly half the variability in fecal weight in ulcerative colitis. Crohn's patients had elevated mean fecal water osmolality and osmotic gap not observed in ulcerative colitis. Increased lactic acid and/or deficient short-chain fatty acids may modulate the diarrhea of ulcerative colitis. This mechanism seems less important in Crohn's colitis where an additional osmotic component may be significant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180970     DOI: 10.1007/bf01536987

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Aetiology and diagnosis of fermentative diarrhoeas.

Authors:  H A WEIJERS; J H VAN DE KAMER
Journal:  Acta Paediatr       Date:  1963-07       Impact factor: 2.299

Review 2.  Diarrhea: a current view of the pathophysiology.

Authors:  S F Phillips
Journal:  Gastroenterology       Date:  1972-09       Impact factor: 22.682

3.  Effect of luminal pH on the absorption of water, Na + and Cl-by rat intestine in vivo.

Authors:  B Rousseau; G E Sladen
Journal:  Biochim Biophys Acta       Date:  1971-06-01

4.  Fecal acidorrhea.

Authors:  L Bustos Fernández; E Gonzalez; A Marzi; M I Ledesma de Paolo
Journal:  N Engl J Med       Date:  1971-02-11       Impact factor: 91.245

5.  Role of the small bowel and colon in lactose-induced diarrhea.

Authors:  N L Christopher; T M Bayless
Journal:  Gastroenterology       Date:  1971-05       Impact factor: 22.682

6.  Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Authors:  R L Bown; J A Gibson; G E Sladen; B Hicks; A M Dawson
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

7.  Effect of lactate and H+ on structure and function of rat intestine.

Authors:  D R Saunders; J Sillery
Journal:  Dig Dis Sci       Date:  1982-01       Impact factor: 3.199

8.  Increased consumption of refined carbohydrates in patients with Crohn's disease.

Authors:  G A Martini; J W Brandes
Journal:  Klin Wochenschr       Date:  1976-04-15

9.  Intense nutritional support in inflammatory bowel disease: a review.

Authors:  R F Kushner; R M Craig
Journal:  J Clin Gastroenterol       Date:  1982-12       Impact factor: 3.062

10.  Total parenteral nutrition and complete bowel rest in the management of Crohn's disease.

Authors:  M J Ostro; G R Greenberg; K N Jeejeebhoy
Journal:  JPEN J Parenter Enteral Nutr       Date:  1985 May-Jun       Impact factor: 4.016

View more
  61 in total

1.  Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease.

Authors:  K Ewe; S Schwartz; S Petersen; A G Press
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

2.  The Guanine Nucleotide Exchange Factor Brx: A Link between Osmotic Stress, Inflammation and Organ Physiology and Pathophysiology.

Authors:  Tomoshige Kino; James H Segars; George P Chrousos
Journal:  Expert Rev Endocrinol Metab       Date:  2010-07-01

Review 3.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.

Authors:  Aonghus Lavelle; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-19       Impact factor: 46.802

Review 4.  [What is the role of nutrition in ulcerative colitis? A contribution to the current status of diet therapy in treatment of inflammatory bowel diseases].

Authors:  M Bartels; E Nagel; R Pichlmayr
Journal:  Langenbecks Arch Chir       Date:  1995

Review 5.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

6.  Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial.

Authors:  Osamu Kanauchi; Toshihiro Suga; Masahiro Tochihara; Toshifumi Hibi; Makoto Naganuma; Terasu Homma; Hitoshi Asakura; Hiroshi Nakano; Kazuya Takahama; Yoshihide Fujiyama; Akira Andoh; Takashi Shimoyama; Nobuyuki Hida; Ken Haruma; Hideki Koga; Keiichi Mitsuyama; Michio Sata; Masanobu Fukuda; Atsushi Kojima; Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

7.  Segmental differences in short-chain fatty acid transport in rabbit colon: effect of pH and Na.

Authors:  J H Sellin; R DeSoignie; S Burlingame
Journal:  J Membr Biol       Date:  1993-11       Impact factor: 1.843

8.  Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.

Authors:  M A Chapman; M F Grahn; M A Boyle; M Hutton; J Rogers; N S Williams
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5.

Authors:  Tomoshige Kino; Hiroaki Takatori; Irini Manoli; Yonghong Wang; Anatoly Tiulpakov; Marc R Blackman; Yan A Su; George P Chrousos; Alan H DeCherney; James H Segars
Journal:  Sci Signal       Date:  2009-02-10       Impact factor: 8.192

10.  Ste20-related proline/alanine-rich kinase (SPAK) regulated transcriptionally by hyperosmolarity is involved in intestinal barrier function.

Authors:  Yutao Yan; Guillaume Dalmasso; Hang Thi Thu Nguyen; Tracy S Obertone; Shanthi V Sitaraman; Didier Merlin
Journal:  PLoS One       Date:  2009-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.